Trial intelligence / Profile preview

Phase III Study of Paratyphoid A Conjugate Vaccine

CTR20132286Phase 3Active

Sponsor
Lanzhou Institute of Biological Products Co., Ltd.
Start
Mar 2016
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of paratyphoid A conjugate vaccine in paratyphoid fever, sponsored by Lanzhou Institute of Biological Products Co., Ltd.. Started Mar 2016; status: active.

02

Drugs

paratyphoid A conjugate vaccine
03

Conditions

paratyphoid fever

Beyond the preview

Go deeper on CTR20132286.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20132286.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call